NCT01225068 - Effect of Milnacipran in Chronic Neuropathic Low Back Pain | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

October 31, 2010

Primary Completion Date

January 31, 2012

Study Completion Date

April 30, 2012

Conditions

Low Back Pain

Interventions

DRUG

Milnacipran

Total of 100 mg (50 mg twice a day) for 6 weeks. Option to increase to 200 mg (100 mg twice a day) after two weeks of treatment. Includes gradual escalation and discontinuation for week 1 and after week 6.

DRUG

Placebo

2 matching pills per day for 6 weeks. Option to increase dose after two weeks of treatment. Includes gradual escalation and discontinuation for week 1 and after week 6.

Trial Locations (1)

60611

Northwestern University Feinberg School of Medicine, Chicago